TruSpine Technolgs. - Share Transfer, Director/PDMR dealing and RPT
Announcement provided by
TruSpine Technologies Plc · TSP17/06/2024 17:30
17 June 2024
TruSpine Technologies plc
("TruSpine" or the "Company")
Share Transfer Agreement, Director/PDMR dealing and Related Party Transaction
TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that, the Company together with Geoff Miller, Non-executive Chairman of the Company and a shareholder of the Company ("Shareholder") entered into an agreement, pursuant to which the Shareholder has agreed to transfer 1,500,000 ordinary shares at a price of
Director/PDMR dealing
As Geoff Miller is the Company's Non-executive Chairman, the Share Transfer Agreement constitutes a director dealing. Following the transaction, Mr Miller will hold 14,111,828 ordinary shares in the Company, representing 9.22 per cent. of the Company's current issued share capital. In addition, Mr Miller holds
Related Party Transaction
The entering into the Share Transfer Agreement (the "Transaction") is a related party transaction for the purposes of Rule 4.6 of the AQSE Growth Market Access Rulebook, by virtue of the Company and Geoff Miller, Non-executive Chairman of the Company, being a party to the Share Transfer Agreement. The directors of TruSpine independent of the Transaction confirm that, having exercised reasonable care, skill and diligence, the Transaction is fair and reasonable insofar as the shareholders of TruSpine are concerned.
This announcement contains inside information for the purposes of the
-END-
Enquiries:
|
TruSpine Investor Hub |
|
|
TruSpine Technologies Plc |
Tel: +44 (0)20 7118 0852 |
|
Geoff Miller, Non-executive Chairman |
|
|
|
|
|
Cairn Financial Advisers LLP (AQSE Corporate Adviser) |
Tel: +44 (0)20 7213 0880 |
|
Liam Murray / Ludovico Lazzaretti |
|
|
Peterhouse Capital Limited (Broker & Financial Adviser) |
|
|
Lucy Williams / Duncan Vasey
|
|
|
Novus Communications (PR and IR) |
Tel: +44 (0)1273 704 473 |
|
Alan Green / Jacqueline Briscoe |
Caution regarding forward looking statements
Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.
|
1 |
Details of the person discharging managerial responsibilities
|
|||||
|
a) |
Name: |
Geoff Miller |
||||
|
2 |
Reason for the Notification |
|||||
|
a) |
Position/Status: |
Director
|
||||
|
b) |
Initial notification/ Amendment: |
Initial Notification
|
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name: |
TruSpine Technologies Plc
|
||||
|
b) |
LEI: |
213800HNZX9B1QZPB225
|
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument: Identification code: |
Ordinary shares of
ISIN: GB00BMZCKL55 |
||||
|
b) |
Nature of the transaction: |
Acquisition of shares
|
||||
|
c) |
Price(s) and Volume(s):
|
|
||||
|
d) |
Aggregated Information: - Aggregated Volume - Price |
N/A
|
||||
|
e) |
Date of the Transaction: |
17 June 2024
|
||||
|
f) |
Place of the Transaction: |
London |
||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
